As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.
Last month, during a forum organized by US News & World Report, Amy Caro, vice president of health IT programs at Northrop
Northrop Grumman received the award under the BioWatch Gen-3 System Performance Demonstration Contract, and said that the contract could be worth up to $37 million over three years.
Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.
The firms won grants to develop integrated diagnostic systems used to counter natural or man-made biological threats.
The companies will use Luminex's xMAP technology to develop an automated biothreat detection tool for a US biosecurity network.
Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.
King's College London researchers examine the influence of school type and genetics on academic achievement.
FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.
In Science this week: early life experience influence somatic variation in the genome, and more.